Skip to content
Sign in
European CDMOs compared · 2026 census

CDMOs in Portugal: 8 compared (2026)

8 of the 255 contract development and manufacturing organisations in A4BEE’s European census are headquartered in Portugal. The largest, with revenue over €1bn, are Hovione. 3 sit between €250m and €1bn and 4 are smaller or niche.

By ownership: 6 family-owned, 1 private equity and 1 part of a pharma or industrial group. The most common capabilities are oral solid dose (6), sterile fill-finish (6), small-molecule API (2), microbial and protein (2) and biologics and biosimilars (1). 4 of the 8 rows rest on audited reports or official company disclosures; the rest come from secondary sources or estimates.

Open these 8 in the interactive mapAll 255 European CDMOs

8 companies

CDMOs in Portugal

CompanyHQOwnershipSizeRevenue (as reported)ModalitiesData
HovioneFully integrated specialist CDMO: API, particle engineering/spray drying, drug product. FDA-inspected across 3 continents.LouresFamily-ownedVillax familyTier 1not disclosedSmall-molecule API, Oral solid dosehigh
BluepharmaIntegrated CRDMO. OSD capacity ~2bn units/year plus complex injectables and LNP work. FDA-inspected 5×.CoimbraFamily-ownedTier 2not disclosedOral solid dose, Sterile fill-finishhigh
CIPANAPI CDMO via fermentation and chemical synthesis (founded 1960). FDA-approved; anti-infectives, psychotropics. Part of Suanfarma.Castanheira do RibatejoPrivate equitySuanfarmaTier 2not disclosedSmall-molecule API, Microbial and proteinhigh
Tecnimede (Atlantic Pharma)Primarily own-product/generics group that also offers contract manufacturing (solids/semi-solids/liquids). CMO secondary.SintraFamily-ownedTecnimede GroupTier 2not disclosedOral solid dose, Sterile fill-finishmedium
GenIbet BiopharmaceuticalsBiologics CDMO: microbial, cell culture, viral process dev + cGMP manufacture plus fill-finish. Made mRNA material for Moderna.OeirasPart of a pharma or industrial groupRecipharmTier 3not disclosedBiologics and biosimilars, Microbial and protein, Viral vector and vaccine, Cell and gene therapy, mRNA and LNP, Sterile fill-finishhigh
Laboratórios BasiPortuguese pharma (since 1956) offering contract manufacturing for injectables, gels, creams and oral solutions. CMO secondary.MortáguaFamily-ownedTier 3not disclosedSterile fill-finish, Oral solid dosemedium
LusomedicamentaManufacturer of solid, liquid and semi-solid dosage forms; explicitly lists contract manufacturing. Exports to 47 countries.QueluzFamily-ownedTier 3not disclosedOral solid dose, Sterile fill-finishmedium
MedinfarOperates a CMO/CDMO industrial unit (~20 yrs) alongside its own portfolio; finished dosage forms, galenic, packaging.AmadoraFamily-ownedTier 3not disclosedOral solid dose, Sterile fill-finishmedium

Size: Tier 1 (revenue over €1bn) · Tier 2 (€250m–€1bn) · Tier 3 (under €250m or niche).

Revenue, staff and site figures are as reported and mix audited accounts with commercial estimates, which are often wrong for private companies. Each row carries a confidence mark; verify a figure before quoting it.

Browse the census

Other European CDMO lists